TrialOncotarget2016

microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.

Mariko Obayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.